CANADIAN BURDEN OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: FINAL RESULTS

被引：0
|
作者：
Zaour, N. [1 ]
Heisel, O. [2 ]
Leteneux, C. [3 ]
Ma, P. [4 ]
机构：
[1] Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada
[2] Syreon Corp, Vancouver, BC, Canada
[3] Novartis Pharma AG, Basel, Switzerland
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1657
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS10
引用
收藏
页码：A284 / A285
页数：2
相关论文
共 50 条
  • [21] Lacquer crack formation and choroidal neovascularization in pathologic myopia
    Ikuno, Yasushi
    Sayanagi, Kaori
    Soga, Kaori
    Sawa, Miki
    Gomi, Fumi
    Tsujikawa, Motokazu
    Tano, Yasuo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (08): : 1124 - 1131
  • [22] Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia
    Ozkiris, Abdullah
    Tuzcu, Esra Ahan
    Erkilic, Kuddusi
    Ilhan, Ozgur
    Oner, Ayse
    Yarbag, Abdulhekim
    Pangal, Emine
    ERCIYES MEDICAL JOURNAL, 2008, 30 (04) : 238 - 241
  • [23] Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab
    Laud, Ketan
    Spaide, Richard F.
    Freund, K. Bailey
    Slakter, Jason
    Klancnik, James M., Jr.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (08): : 960 - 963
  • [24] Ocular Risk Factors for Choroidal Neovascularization in Pathologic Myopia
    Ikuno, Yasushi
    Jo, Yukari
    Hamasaki, Toshimitsu
    Tano, Yasuo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (07) : 3721 - 3725
  • [25] Nine-Year Outcome of Ranibizumab Monotherapy for Choroidal Neovascularization Secondary to Pathologic Myopia
    Pastore, Marco R.
    Capuano, Vittorio
    Bruyere, Elsa
    Miere, Alexandra
    Corbelli, Eleonora
    Querques, Lea
    Tognetto, Daniele
    Bandello, Francesco
    Querques, Giuseppe
    Souied, Eric H.
    OPHTHALMOLOGICA, 2018, 239 (2-3) : 133 - 142
  • [26] Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia
    Tewari, Asheesh
    Dhalla, Mandeep S.
    Apte, Rajendra S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (09): : 1093 - 1094
  • [27] Fluorescein Leakage and Optical Coherence Tomography Features of Choroidal Neovascularization Secondary to Pathologic Myopia
    Parodi, Maurizio Battaglia
    Iacono, Pierluigi
    Romano, Francesco
    Bandello, Francesco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (07) : 3175 - 3180
  • [28] RADIANCE: A Randomized Controlled Study of Ranibizumab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia
    Wolf, Sebastian
    Balciuniene, Vilma Jurate
    Laganovska, Guna
    Menchini, Ugo
    Ohno-Matsui, Kyoko
    Sharma, Tarun
    Wong, Tien Y.
    Silva, Rufino
    Pilz, Stefan
    Gekkieva, Margarita
    OPHTHALMOLOGY, 2014, 121 (03) : 682 - U108
  • [29] INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION COMPLICATING PATHOLOGIC MYOPIA
    Lalloum, Franck
    Souied, Eric H.
    Bastuji-Garin, Sylvie
    Puche, Nathalie
    Querques, Giuseppe
    Glacet-Bernard, Agnes
    Coscas, Gabriel
    Soubrane, Gisele
    Leveziel, Nicolas
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (03): : 399 - 406
  • [30] Factors associated with the recurrence of choroidal neovascularization in pathologic myopia
    Jing, Ruixia
    Bo, Yuxia
    Gao, Lei
    Wang, Zhen
    FRONTIERS IN MEDICINE, 2022, 9
12345